Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Shares of Hims & Hers, which has clashed with Novo Nordisk over its sales of compounded glucagon-like peptide inhibitors, rose slightly in the wake of the report, and have more than doubled in value ...

Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its ...

One of the more popular stocks in the pharmaceutical sector of late got the cold shoulder from investors on Tuesday. Eli Lilly (NYSE: LLY) closed today's trading session down by almost 6% in value, ...

Import duties on Chinese goods could surge to about 80% if the pause expires on Aug. 12. Plus: UnitedHealth Group said its ...

Robin Roberts Leaves GMA for an 'Incredible Journey' Abroad with Her Wife Amber Laign PGAT Winner Playfully Asks Compensation Over $720K Text Sent To Colleague Health officials warn of dangerous ...

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

Novo Nordisk selloff is an overreaction. With solid fundamentals, a strong drug pipeline & long-term upside, discover why ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...